Renal Safety of de Novo Angiotensin-Neprilysin Inhibition in Older Adults: Insights From a Population-Based Analysis

J Card Fail. 2023 Feb;29(2):147-149. doi: 10.1016/j.cardfail.2022.11.013. Epub 2022 Dec 15.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Aminobutyrates
  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensins*
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure*
  • Humans
  • Neprilysin
  • Tetrazoles
  • Valsartan

Substances

  • Angiotensins
  • Neprilysin
  • Valsartan
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin Receptor Antagonists
  • Aminobutyrates
  • Tetrazoles
  • Biphenyl Compounds
  • Drug Combinations